The antimetastatic and antitumor effect of bpDNase I and its ability to destroy tumor-derived cfDNA has been demonstrated in murine models of melanoma B16 and resistant lymphosarcoma RLS40, which indicates the general patterns of the DNase I functioning in metastases and tumor inhibition [63]. The gene discussed is DNASE1L3; the disease is neoplasm.